The OPDP sent its second untitled letter this week, this time to Durect and Pain Therapeutics over the presentation of Remoxy ER.
Alexion launched a new superhero-themed awareness campaign to draw attention to four rare diseases that its products treat.
The consultancy includes Double Helix, which was acquired by McCann in 2012.
